Labelling changes for cimicifuga in Australia

By  

Reactions Weekly, Vol. 1, Iss. 1155, 2007-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Are Cancer Drugs Less Likely to be Recommended for Listing by the Pharmaceutical Benefits Advisory Committee in Australia?

By Chim Lesley   Kelly Patrick J.   Salkeld Glenn   Stockler Martin R.  

PharmacoEconomics, Vol. 28, Iss. 6, 2010-06 ,pp. : 463-475

Adis International

Access to resources Recommend Favorite

European countries aim for collaboration on HTA

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 617, 2010-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Report card on HTA: room for improvement

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 591, 2009-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

A Proposal for a Pharmacokinetic Interaction Significance Classification System (PISCS) Based on Predicted Drug Exposure Changes and Its Potential Application to Alert Classifications in Product Labelling

By Hisaka Akihiro  

Clinical Pharmacokinetics, Vol. 48, Iss. 10, 2009-10 ,pp. : 653-666

Adis International

Access to resources Recommend Favorite